Annis Gardner Whiting Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $873K | Buy |
1,961
+22
| +1% | +$9.79K | 0.3% | 73 |
|
|
2025
Q1 | $940K | Sell |
1,939
-5
| -0.3% | -$2.42K | 0.4% | 56 |
|
|
2024
Q4 | $783K | Hold |
1,944
| – | – | 0.22% | 84 |
|
|
2024
Q3 | $904K | Sell |
1,944
-61
| -3% | -$28.4K | 0.25% | 75 |
|
|
2024
Q2 | $940K | Buy |
2,005
+1,809
| +923% | +$848K | 0.27% | 70 |
|
|
2024
Q1 | $81.9K | Buy |
196
+40
| +26% | +$16.7K | 0.03% | 311 |
|
|
2023
Q4 | $63.5K | Hold |
156
| – | – | 0.03% | 273 |
|
|
2023
Q3 | $54.2K | Buy |
+156
| New | +$54.2K | 0.03% | 275 |
|